STI Stock Trade Intelligence
IMM

IMMUTEP LIMITED

Health Care · ASX:IMM
$0.0240
▼ -4.00%
Market cap
$35M
Turnover
$140,901
Last price
$0.0240
Day change
-4.00%
Announcements
9
Range, past year
Open 0.280 · Low 0.020 · Now 0.024 · High 0.470
Open IMM in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

IMM momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-11-16.
Momentum quality
30/100
Wyckoff phase
Downtrend56d
Trend stage
Neutral
1 Day
-4.0%
1 Week
-7.7%
1 Month
+4.3%
RSI
44
Avg daily range
10.1%

IMMUTEP LIMITED scores 30 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.

On the Wyckoff cycle it sits in Downtrend, where it has been for 56 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.

Against the wider market it is currently matching and the institutional accumulation signal reads low.

What stands out
  • Trend R² 0.88 — highly linear uptrend
Points to watch
  • 60d drawdown -62.5%
  • High volatility (ATR 10.1%)
  • Risk rating: Very High
  • Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

IMM announcements

Recent price-sensitive releases.
  • 2026-11-09 IMP761 Late-Breaking Abstract at ACR shows T-Cell Inhibition Progress Report
  • 2026-10-29 Immutep Quarterly Activities Report and Appendix 4C Commitments Test Entity - First Quarter Activity Report | Commitments Test Entity - First Quarter Cashflow Report
  • 2026-10-28 Immutep Receives A$2.16 million French R&D Tax Incentive Periodic Reports - Other | Company Administration - Other
  • 2026-09-11 Immutep Outlines Focused Development Strategy for Efti Progress Report
  • 2026-08-31 Appendix 4E & 2026 Full Year Statutory Accounts Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
  • 2026-07-30 Immutep Quarterly Activities Report and Appendix 4C Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
  • 2026-07-13 TACTI-004 Update & Positive Mature Data from INSIGHT-003
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.